Trexquant Investment LP Chembio Diagnostics, Inc. Transaction History

Trexquant Investment LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$2.88 - $5.64 $34,994 - $68,531	-12,151 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$3.4 - $7.97 $87,325 - $204,701	-25,684 Reduced 67.88%	12,151 $43,000
Q4 2020 Feb 11, 2021	BUY	$4.11 - $7.51 $155,501 - $284,140	37,835 New	37,835 $180,000

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.